403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Medicenna Therapeutics Corp.
(MENAFN- Baystreet) 09:33 AM EST - Medicenna Therapeutics Corp.: Announced today that, in connection with its previously announced marketed public offering of units of the Company, it has filed a prospectus supplement to the Company's existing short form base shelf prospectus dated June 4, 2025 with the securities commissions in each of Provinces of British Columbia, Alberta and Ontario. Medicenna Therapeutics Corp.
shares T are trading unchanged at $0.44.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment